Early diagnosis and prevention of diabetes is the goal of researchers at The Hong Kong Polytechnic University and Zhejiang University in China. They have reported developing fiber-optic glucose sensors in a microfluidic chip that could be the basis of portable, accurate and inexpensive devices to measure glucose levels in sweat.
Ortho Clinical Diagnostics CEO Martin Madaus told FierceMedicalDevices in an interview that Ortho has been actively investing in building out as a standalone company, which has dragged on earnings in the near term. But he added that Ortho has returned to revenue growth--and is aiming to get to about a 4% run rate.
Researchers in Australia are working on a blood test for Parkinson's disease, and now their efforts just got a financial boost from The Michael J. Fox Foundation for Parkinson's Research.
In this week's Dx Digest, Quest Diagnostics launched hepatitis C test services that help doctors see how patients will respond to certain antiviral therapies, Foundation Medicine revealed new data from more than 1,200 pediatric cancers that could come in handy for developing new drugs for the disease, and Invitae got Medicare reimbursement for its multigene hereditary cancer tests.
Things keep sliding down a slippery slope for Theranos, and now the beleaguered testing company is sinking even deeper. Federal prosecutors are launching a criminal investigation into Theranos, claiming that the company misled investors about its technology and operations.
Theranos CEO Elizabeth Holmes has mostly stayed quiet during the company's fall from grace. But now, the beleaguered testing company's frontwoman is talking. In a Today Show interview with NBC special anchor Maria Shriver, Holmes opened up about Theranos' ongoing testing saga and its recent fallout with the Centers for Medicare and Medicaid Services.
Regulators have had a lot of strong words for Theranos CEO Elizabeth Holmes lately, and now, they're sending a new message to the leader of the embattled testing company: Get out.
Welcome to Dx Digest, where FierceMedicalDevices highlights the highs and sometimes lows of the past week in the diagnostics industry. Testing heavyweight Siemens got an FDA nod for its Graves' disease (GD) test. Epigenomics also got a regulatory blessing for its colorectal cancer screening tool. Last but certainly not least, NanoString Technologies and HalioDx teamed up to develop immuno-oncology gene expression tests.
Adavium Medical has made a lot of moves fast to thrust itself into the position of the largest medical equipment and diagnostics company in Brazil. It just acquired two of the largest Brazilian clinical diagnostics companies, raised a $21 million Series C round to finance these and other anticipated deals, hired an ex-GE Healthcare exec as COO and president of diagnostics and changed its name from Advance Medical.
In this week's Dx Digest, liquid biopsy upstart Liquid Biotech got $1 million for positive clinical results for its lung and bladder cancer test; big-name investors including Jeff Bezos and Bill Gates are sinking money into liquid biopsy, the diagnostic industry's new cash cow; and health diagnostics company Avioq is selling out to a Chinese company for $65 million.